BMSSC
INSM icon

B. Metzler seel. Sohn & Co’s Insmed INSM Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.42M Buy
39,243
+34,510
+729% +$5.31M 0.06% 180
2025
Q4 		$824K Sell
4,733
-348
-7% -$63.5K 0.01% 573
2025
Q3 		$732K Sell
5,081
-5,429
-52% -$665K 0.01% 599
2025
Q2 		$1.06M Hold
10,510
– – 0.01% 530
2025
Q1 		$802K Hold
10,510
– – 0.01% 568
2024
Q4 		$726K Hold
10,510
– – 0.01% 595
2024
Q3 		$767K Buy
+10,510
New +$776K 0.01% 592
2024
Q2 		– Sell
-18,672
Closed -$507K – 771
2024
Q1 		$507K Hold
18,672
– – 0.01% 618
2023
Q4 		$579K Buy
18,672
+2,051
+12% +$53.2K 0.01% 593
2023
Q3 		$420K Sell
16,621
-13,969
-46% -$319K 0.01% 603
2023
Q2 		$645K Buy
30,590
+16,423
+116% +$312K 0.01% 551
2023
Q1 		$242K Buy
14,167
+955
+7% +$18.6K ﹤0.01% 665
2022
Q4 		$264K Hold
13,212
– – ﹤0.01% 650
2022
Q3 		$285K Buy
13,212
+1,076
+9% +$25.8K 0.01% 643
2022
Q2 		$239K Hold
12,136
– – ﹤0.01% 679
2022
Q1 		$285K Buy
+12,136
New +$282K ﹤0.01% 698

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

B. Metzler seel. Sohn & Co's INSM Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co increased its Insmed (INSM) stake by 729% in Q1 2026, buying an estimated $5.31M and bringing the position to 39,243 shares worth $6.42M. The position accounts for 0.06% of the portfolio, ranked #180.

B. Metzler seel. Sohn & Co first reported a position in INSM in Q1 2022 and has held it in 16 quarters since. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • B. Metzler seel. Sohn & Co held 39,243 shares of Insmed worth $6.42M as of Q1 2026.
  • B. Metzler seel. Sohn & Co bought 34,510 Insmed shares in Q1 2026, an estimated $5.31M.
  • Insmed made up 0.06% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #180 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Insmed in Q1 2022 and has held it in 16 quarters since.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.